semaglutide and stomach issues Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common stomach issues after semaglutide Semaglutide

Targets like TLR4, TRPV1, BDNF, and NLRP3 along the spinal cord become direct gateways for adaptogenic or neuroprotective molecules

Acknowledgements This work was supported by the MICINN Retos MICIN/AEI/10.13039/501100011033, PID2020-117827RB-I00 and MICIN/AEI/10.13039/501100011033 PID2020-117941RB-I00, PID2023-150260OB-I00 and PID2023-151347OB-I00, all of which were co-financed with Fondos FEDER, EXOHEP2-CM (S2022/BMD-7409), and HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679

Adiponectin enhances skeletal muscle fatty acid oxidation and glucose uptake through AMPK activation, while lowering hepatic gluconeogenesis [36]

References Ejtahed H-S, Soroush A-R, Angoorani P, Larijani B, Hasani-Ranjbar S

For instance, in the STEP 2 trial, nausea rates rose from 5% at the initial 0.25 mg dose to 15% when patients reached the 2.4 mg dose of semaglutide

One area receiving increasing attention is their effect on GLP-1 , a powerful gut hormone that plays a central role in blood sugar balance, appetite regulation, and metabolic health